Animal Drug Compounding Market Size is valued at 2.36 billion in 2024 and is predicted to reach 5.15 billion by the year 2034 at an 8.2% CAGR during the forecast period for 2025-2034.
As more pet parents learn about the benefits of compounded drugs, which is projected to inspire more people to adopt them, the market will expand. The industry has also seen potential due to the rising need for individualized and specialized medications for companion animals and the expanding animal population and longer life spans. Furthermore, a rise in the prescriptions for animal-compounded medicines is anticipated to fuel market expansion. The FDA reports that 6.3 million prescriptions for compounded animal medications are written by veterinarians each year in the United States.
Like many other global businesses, the COVID-19 pandemic had a detrimental effect on the market for animal medication compounding in 2020. According to reports, supply chain interruptions, a decline in sales, a decrease in demand, and operational difficulties brought on by changing regulations and policies are the most critical effects of COVID-19 on the veterinary healthcare system. Due to widespread lockdowns and limitations on the movement of persons and commodities, manufacturing companies, pharmacies, and veterinary service providers were severely impacted. For instance, the American Veterinary Medical Association reports that the coronavirus outbreak caused the cancellation or delay of around 60% of veterinary services in April 2020. By July 2020, the number had fallen to roughly 30%.
The Animal Drug Compounding market is segmented based on animal type, product, route of administration, and dosage form. Based on animal type, the market is segmented as Companion Animals, Dogs, Cats, Others, and Livestock Animals. The product segment includes Anti-infective Agents, Anti-inflammatory Agents, Hormones & Substitutes, CNS Agents, and others. By route of administration, the market is segmented into Oral, Injectable, Topical, and Others. The dosage form segment includes Suspensions, Solutions, and Capsules.
By animal type, the companion animal market accounted for the highest proportion of the global animal medication compounding market in 2022. Similarly, it is anticipated that over the next few years, the companion animal segment will expand at the fastest rate, exceeding 8%. This market is developing as a result of factors like an increase in the number of companion animals, rising pet care costs, increased knowledge of animal medicine compounding among pet owners and veterinarians, and the many advantages it offers companion animals.
While CNS agents are the most frequently prescribed treatment for treating neurological problems such as a change in behaviour, blindness, seizures, etc., in pets, these sectors dominated the global market for animal drug compounding. In veterinary medicine, a variety of pharmacological classes are employed as CNS or psychotropic drugs. Among them are anxiolytics, anticonvulsants, tranquillizers, analgesics, sedatives, antidepressants, antipsychotics, and others. Several CNS agents are available from businesses like Wedgewood Pharmacy that are formulated for particular medical conditions.
During the forecast period, Asia Pacific is anticipated to have the fastest CAGR. The rise in pet humanization, rising costs for veterinary treatment, and the accessibility of affordable animal compounded pharmaceuticals are the leading causes of the expansion. A surge in demand for compounded veterinary pharmaceuticals, notably for pets and non-food-producing animals in the region, as well as increased investment by international players to enhance their presence in this region, are also projected to fuel the market's expansion.
|
Report Attribute |
Specifications |
|
Market size value in 2024 |
USD 2.36 Bn |
|
Revenue forecast in 2034 |
USD 5.15 Bn |
|
Growth rate CAGR |
CAGR of 8.2% from 2025 to 2034 |
|
Quantitative units |
Representation of revenue in US$ Billion, and CAGR from 2025 to 2034 |
|
Historic Year |
2021 to 2024 |
|
Forecast Year |
2025-2034 |
|
Report coverage |
The forecast of revenue, the position of the company, the competitive market statistics, growth prospects, and trends |
|
Segments covered |
Animal Type, Product, Route Of Administration, And Dosage Form |
|
Regional scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; South Korea; Southeast Asia |
|
Competitive Landscape |
Wedgewood Pharmacy; Vimian; Pharmaca; Akina Animal Health; Triangle Compounding; Davis Islands Pharmacy and Compounding Lab; Custom Med Compounding Pharmacy; Central Compounding Center South; Wellness Pharmacy of Cary; Miller's Pharmacy. |
|
Customization scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing and available payment methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Animal Drug Compounding Market Snapshot
Chapter 4. Global Animal Drug Compounding Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Animal Type Estimates & Trend Analysis
5.1. by Animal Type & Market Share, 2024 & 2034
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Animal Type:
5.2.1. Companion Animals
5.2.1.1. Dogs
5.2.1.2. Cats
5.2.1.3. Others
5.2.2. Livestock Animals
Chapter 6. Market Segmentation 2: by Products Estimates & Trend Analysis
6.1. by Products & Market Share, 2024 & 2034
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Products:
6.2.1. Anti-infectives
6.2.1.1. Metranidazole
6.2.1.2. Ketaconazole
6.2.1.3. Others
6.2.2. Anti-inflammatory
6.2.2.1. Prednisolone
6.2.2.2. Tramadol
6.2.2.3. Others
6.2.3. CNS Agents
6.2.3.1. Potassium Bromide
6.2.3.2. Gabapentin
6.2.3.3. Other CNS Agents
6.2.4. GI Drugs
6.2.4.1. Apomorphine
6.2.4.2. Ursodiol
6.2.4.3. Cisapride
6.2.4.4. Other GI Drugs
6.2.5. Others
6.2.5.1. Methimazole
6.2.5.2. Others
Chapter 7. Market Segmentation 3: by Route of Administration Estimates & Trend Analysis
7.1. by Route of Administration & Market Share, 2024 & 2034
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Route of Administration:
7.2.1. Oral
7.2.2. Injectable
7.2.3. Topical
7.2.4. Others
Chapter 8. Market Segmentation 4: by Form Estimates & Trend Analysis
8.1. by Form & Market Share, 2024 & 2034
8.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Form:
8.2.1. Suspensions
8.2.2. Solutions
8.2.3. Capsules
Chapter 9. Animal Drug Compounding Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. North America Animal Drug Compounding Market Revenue (US$ Million) Estimates and Forecasts by Animal Type, 2021-2034
9.1.2. North America Animal Drug Compounding Market Revenue (US$ Million) Estimates and Forecasts by Products, 2021-2034
9.1.3. North America Animal Drug Compounding Market Revenue (US$ Million) Estimates and Forecasts by Route of Administration, 2021-2034
9.1.4. North America Animal Drug Compounding Market Revenue (US$ Million) Estimates and Forecasts by Form, 2021-2034
9.1.5. North America Animal Drug Compounding Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
9.2. Europe
9.2.1. Europe Animal Drug Compounding Market Revenue (US$ Million) Estimates and Forecasts by Animal Type, 2021-2034
9.2.2. Europe Animal Drug Compounding Market Revenue (US$ Million) Estimates and Forecasts by Products, 2021-2034
9.2.3. Europe Animal Drug Compounding Market Revenue (US$ Million) Estimates and Forecasts by Route of Administration, 2021-2034
9.2.4. Europe Animal Drug Compounding Market Revenue (US$ Million) Estimates and Forecasts by Form, 2021-2034
9.2.5. Europe Animal Drug Compounding Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
9.3. Asia Pacific
9.3.1. Asia Pacific Animal Drug Compounding Market Revenue (US$ Million) Estimates and Forecasts by Animal Type, 2021-2034
9.3.2. Asia Pacific Animal Drug Compounding Market Revenue (US$ Million) Estimates and Forecasts by Products, 2021-2034
9.3.3. Asia-Pacific Animal Drug Compounding Market Revenue (US$ Million) Estimates and Forecasts by Route of Administration, 2021-2034
9.3.4. Asia-Pacific Animal Drug Compounding Market Revenue (US$ Million) Estimates and Forecasts by Form, 2021-2034
9.3.5. Asia Pacific Animal Drug Compounding Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
9.4. Latin America
9.4.1. Latin America Animal Drug Compounding Market Revenue (US$ Million) Estimates and Forecasts by Animal Type, 2021-2034
9.4.2. Latin America Animal Drug Compounding Market Revenue (US$ Million) Estimates and Forecasts by Products, 2021-2034
9.4.3. Latin America Animal Drug Compounding Market Revenue (US$ Million) Estimates and Forecasts by Route of Administration, 2021-2034
9.4.4. Latin America Animal Drug Compounding Market Revenue (US$ Million) Estimates and Forecasts by Form, 2021-2034
9.4.5. Latin America Animal Drug Compounding Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
9.5. Middle East & Africa
9.5.1. Middle East & Africa Animal Drug Compounding Market Revenue (US$ Million) Estimates and Forecasts by Animal Type, 2021-2034
9.5.2. Middle East & Africa Animal Drug Compounding Market Revenue (US$ Million) Estimates and Forecasts by Products, 2021-2034
9.5.3. Middle East & Africa Animal Drug Compounding Market Revenue (US$ Million) Estimates and Forecasts by Route of Administration, 2021-2034
9.5.4. Middle East & Africa Animal Drug Compounding Market Revenue (US$ Million) Estimates and Forecasts by Form, 2021-2034
9.5.5. Middle East & Africa Animal Drug Compounding Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. Akina Animal Health
10.2.2. Aurora Compounding
10.2.3. Caringbah Compounding Pharmacy
10.2.4. Central Compounding Center South
10.2.5. Chiron Compounding Pharmacy
10.2.6. Custom Med Compounding Pharmacy
10.2.7. Davis Islands Pharmacy and Compounding Lab
10.2.8. Dougherty's Pharmacy
10.2.9. Hoye's Pharmacy
10.2.10. Medisca Inc.
10.2.11. MEDS Canadian Compounding Pharmacy
10.2.12. Millers Pharmacy
10.2.13. Pace Pharmacy
10.2.14. People’s Choice Pharmacy
10.2.15. Pharmaca.
10.2.16. Pratt’s Compounding Pharmacy
10.2.17. Sixth Avenue Medical Pharmacy
10.2.18. Smith Caldwell Drug Store
10.2.19. Smith’s Pharmacy
10.2.20. Specialist Compounding Pharmacy Pte Ltd.
10.2.21. Tache Pharmacy
10.2.22. Triangle Compounding Pharmacy Inc.
10.2.23. Vertisis Custom Pharmacy
10.2.24. Victoria Compounding Pharmacy
10.2.25. Vimian
10.2.26. Wedgewood Pharmacy
10.2.27. Wellness Pharmacy of Cary
10.2.28. Other Prominent Players
Animal Drug Compounding Market By Animal Type-
Animal Drug Compounding Market By Product-
Animal Drug Compounding Market By Route of Administration-
Animal Drug Compounding Market By Dosage Form-
Animal Drug Compounding Market By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
